Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Sunshine Biopharma closes $6 million public offering with potential additional $14.4 million from warrant exercises.
Amount Raised
$6 Million
Round Type
Post-IPO Equity
Investors
Description
Sunshine Biopharma Inc. (NASDAQ: SBFM) closed its public offering on October 9, 2026, securing $6.0 million in upfront gross proceeds. The offering consisted of 10,909,082 Common Units or Pre-Funded Units, each comprising one share of Common Stock or one Pre-Funded Warrant paired with two Series D Warrants. The transaction includes potential for an additional $14.4 million in gross proceeds if Series D warrants are fully exercised, bringing total potential aggregate proceeds to approximately $20.4 million
Fundz sees it the moment Sunshine Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sunshine Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.